ZOMEDICA CORP (ZOM) Stock Analyst Earnings Estimates
NYSEARCA:ZOM - NYSE Arca - CA98980M1095 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.133M | 18.93M 358.01% | 25.186M 33.05% | 27.775M 10.28% | 35.552M 28.00% | 45.783M 28.78% | 59.166M 29.23% | |
| EBITDA YoY % growth | -20.228M -24.60% | -17.881M 11.60% | -25.294M -41.46% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -21.368M -27.46% | -21.923M -2.60% | -31.592M -44.10% | -51.413M -62.74% | -35.525M 30.90% | -33.999M 4.30% | -36.988M -8.79% | |
| Operating Margin | -516.99% | -115.81% | -125.43% | -185.11% | -99.92% | -74.26% | -62.52% | |
| EPS YoY % growth | N/A | N/A | -0.02 -13.86% | -0.05 -110.78% | -0.03 37.50% | -0.03 10.00% | -0.03 -11.11% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 29.30% | -0.01 19.20% | -0.01 | -0.01 19.20% | -0.01 -14.29% |
| Revenue Q2Q % growth | 8.181M 11.50% | 7.878M 25.85% | 8.585M 40.05% | 8.989M 28.41% | 10.1M 23.46% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.091M 28.96% | -8.879M 14.51% | -8.784M 2.86% | -8.993M -20.87% | -8.869M -9.61% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.01 -900.00% | 0.00 | -0.01 | % |
| Q2 2024 Q2Q % growth | 0.00 100.00% | 0.00 | 0.00 | % |
| Q1 2024 Q2Q % growth | -0.01 -42.86% | 0.00 | -0.01 | % |
| Q4 2023 Q2Q % growth | -0.01 -66.67% | 0.00 | -0.01 | % |
| Q3 2023 Q2Q % growth | 0.00 80.00% | 0.00 | 0.00 | % |
| Q4 2022 Q2Q % growth | -0.01 | -0.01 | 0.00 | 40.59% |
| Q4 2020 Q2Q % growth | -0.01 66.67% | 0.00 | -0.01 | % |
| Q3 2020 Q2Q % growth | -0.01 66.67% | 0.00 | -0.01 | % |
| Q2 2020 Q2Q % growth | -0.02 | -0.01 | -0.01 | -98.02% |
| Q4 2019 Q2Q % growth | -0.03 | -0.02 | -0.01 | -48.51% |
| Q3 2019 Q2Q % growth | -0.03 | -0.02 | -0.01 | -48.51% |
| Q2 2019 Q2Q % growth | -0.02 | -0.06 | 0.04 | 67.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 7M 10.29% | 8.783M | -1.783M | -20.30% |
| Q2 2024 Q2Q % growth | 6.13M 1.83% | 8.439M | -2.309M | -27.36% |
| Q1 2024 Q2Q % growth | 6.26M 14.19% | 8.266M | -2.006M | -24.27% |
| Q4 2023 Q2Q % growth | 7.337M 19.17% | 7.07M | 267K | 3.78% |
| Q3 2023 Q2Q % growth | 6.347M 32.89% | 8.368M | -2.021M | -24.15% |
| Q2 2023 Q2Q % growth | 6.02M 41.78% | 7.413M | -1.393M | -18.79% |
| Q1 2023 Q2Q % growth | 5.482M 46.15% | 6.696M | -1.214M | -18.13% |
| Q4 2022 Q2Q % growth | 6.157M 50.88% | 6.262M | -105K | -1.68% |
| Q3 2022 Q2Q % growth | 4.776M 21,117.24% | % | ||
| Q2 2022 Q2Q % growth | 4.246M 26,961.82% | % | ||
| Q1 2022 Q2Q % growth | 3.751M 26,465.16% | % | ||
| Q1 2020 Q2Q % growth | 405.999K | -405.999K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -380% | -380% |
| Revenue | 0% | 0% | 0% | -19.35% |